Autologous dendritic cells and activated cytotoxic T‑cells as combination therapy for breast cancer
Julia Shevchenko(Research Institute of Fundamental and Clinical Immunology), С. В. Сенников(Research Institute of Fundamental and Clinical Immunology)
Cited by 21
Related Papers
Production of hemo- and immunoregulatory cytokines by erythroblast antigen+ and glycophorin A+ cells from human bone marrow
|BMC Cell Biology|2004|35
Modified Dendritic cell-based T-cell expansion protocol and single-cell multi-omics allow for the selection of the most expanded and in vitro-effective clonotype via profiling of thousands of MAGE-A3-specific T-cells
|Frontiers in Immunology|2024|4
Targeting Precision in Cancer Immunotherapy: Naturally-Occurring Antigen-Specific TCR Discovery with Single-Cell Sequencing
|Cancers|2024|4
GD2-Specific CAR T Cells Demonstrate Potent and Targeted Anti-Tumor Efficacy Against Melanoma In Vitro and In Vivo
|Frontiers in Bioscience-Landmark|2025|3